Dr. Jeff Keyser to Receive 2024 Dennis K. Stone Award
for Impact on North Texas Biotech
|
BioNTX is proud to announce Dr. Jeff Keyser, Co-founder and CEO at Renibus Therapeutics as the recipient of the 2024 Dennis K. Stone Award in recognition of his exceptional contributions and impact on North Texas life sciences, biotechnology, and healthcare innovation. The Dennis K. Stone Award is presented annually to an individual whose dedication, leadership, and lasting impact have shaped regional life sciences, biopharma, and healthcare.
Dr. Keyser co-founded ZS Pharma, which was acquired by AstraZeneca in 2015 for $2.7 billion. Having invented the Mucinex product line for Adams Respiratory Therapeutics, he led Adams as VP of Development and Regulatory Affairs until its acquisition by Reckitt Benckiser for $2.3 billion in 2007.
Thank you and Congratulations Dr. Keyser!
|
Jeff Keyser, PhD, RPh, JD
|
iC³ Summit Early-Bird Discounts End Tonight!
|
BioNTX's Early-Bird Discounts for the iC³ Summit are available through Monday, September 9. This is your last chance to secure discounted rates and connect with leading innovators in the industry. Take advantage of this opportunity to be part of the Summit and engage with key players in the field before the offer expires.
|
Meet the 2024 Rising Stars at the iC³ Life Science Summit
|
BioNTX is thrilled to introduce the 2024 Rising Stars— meet these trailblazers at the iC³ Life Science Summit!
We are proud to continue the tradition of showcasing groundbreaking Texas-based companies with up to $100 million in funding or revenue. These exceptional innovators are making significant strides in addressing critical challenges in human health, pharma, and bioscience. Join us in 2024 to support and celebrate these innovative leaders.
|
Book Your Stay at the Loews Arlington Hotel for the iC³ Summit
|
Maximize your iC³ Summit experience and stay at the Loews Arlington Hotel! Enjoy the convenience of being just steps away from all Summit sessions and networking opportunities! Bring the family to Arlington for the summer of a lifetime!
|
BioNTX Breakfast of Champions
|
Join us for the Women’s Breakfast at the iC³ Summit, a gathering dedicated to celebrating the achievements and contributions of women in life sciences, and biotechnology innovation. The morning event will feature an array of breakfast options and provide a platform for networking with peers and professionals sharing personal stories, and discussing the future of women in corporate leadership.
Hear distinguished speaker, Dr. Adora Ndu, Chief Regulatory Officer at BridgeBio Pharma, engage in meaningful conversations and build connections with others who are shaping the future of health and science. This is a rare chance to support remarkable women making a difference and fostering collaboration within industry.
|
BioNTX Announces Finalist of 3rd Annual Tech Transfer Showcase
|
Thin-Film Electrodes on Softening Polymers for Spinal Cord Stimulation
|
Advanced Non-Contact Vital Sign Monitoring with Multi-View Doppler Technology
|
Genetically Primed Therapeutic MSCs
|
Unlocking the healing power of the binding of intracellular proteins to voltage-gated sodium channels for mental illness
|
Endovascular surgical guidewire with ultrasound localization
|
BioNTX is thrilled to announce the applicants advancing to the next round of our 3rd Annual Tech Transfer Showcase. These outstanding innovators have demonstrated exceptional potential, and their technologies will undergo further evaluation as they move closer to the final competition.
Finalists will showcase their work at the iC³ Summit on Friday, October 4th where Winners will be announced.
|
Meet Disruptive Innovators and Visionary Leaders at iC³ 2024
|
Celebrating a Decade of Innovation and Excellence in North Texas
|
Pioneering Space Health: Innovations in Microgravity
and the Future of Cosmic Exploration
|
Probe new frontiers and innovations in microgravity and medicine, discover how Texans are paving the way for future generations to explore space safely.
As humans begin a renewed exploration of the cosmos, garner expert insights as industry thought leaders weigh-in on the latest developments in space health research, missions, ethics, challenges, and innovative solutions being developed to support human missions beyond Earth.
|
Innovating BioManufacturing: Strategies
for Scaling and Sustaining Growth
|
Explore the evolving landscape of biomanufacturing in this insightful session focused on the latest trends, challenges, and innovations shaping the industry. The discussion will delve into strategies for scaling operations, navigating complex regulatory environments, and sustaining growth in a competitive market.
Whether you're a seasoned professional or new to the field, this session offers valuable perspectives on the future of biomanufacturing and the critical factors driving success.
|
2024 EY Texas Report: Building Biotech in Texas
|
For 34 years, Ernst & Young’s Beyond Borders report has provided leading analysis on the biotech and medtech sectors in the US and Europe. Now, with the spotlight on Texas, the Texas edition reveals how North Texas is becoming a major biotech hub.
BioNTX invites you to explore Texas's growing biotech landscape. Join us to hear from top speakers on the opportunities and challenges facing our industry in this dynamic region.
|
Transforming Healthcare with AI & SMART Medical Devices
|
Delve into the latest trends and pressing issues with combining AI/Machine learning into medical devices, with a focus on product design, development and manufacturing, intellectual property, cybersecurity and validation as well as differences in regulatory and clinical pathways for Class I, II and III devices.
Hear visionaries and experts share their experiences and strategies to navigate these challenges to successfully bringing new medical devices to market.
|
Startup Disruption: Trends Driving Success in Emerging Markets
|
Explore the pivotal trends driving success in emerging biotech markets. Obtain a comprehensive analysis of the latest advancements in biotech infrastructure, including state-of-the-art wet labs, incubators, and innovation hubs.
Gain expert insights into the strategic design, management, and operation of specialized facilities, critical to accelerating innovation, fostering groundbreaking research, and creating commercial opportunities in the biotech sector.
|
Innovation to Impact: The Future of Cell & Gene Therapy in Texas
|
Explore the cutting-edge trends and pressing issues in cell and gene therapy, with a focus on the readiness of Texas to support research and development in this transformative field.
Gain insights into the latest scientific advancements, regulatory challenges, and infrastructural needs for conducting cell and gene therapy research. Learn Texas' current capabilities, opportunities, and strategic initiatives to position the state as a leader in cell and gene therapy innovation.
|
iC³ Sponsor Spotlight: Alloy Therapeutics
|
Alloy Therapeutics is a biotechnology ecosystem company dedicated to accelerating drug discovery by providing cutting-edge antibody and bispecific discovery platforms, TCRm services for intracellular targets, and advanced ASO technologies for genetic diseases. With a network of over 170 partners, including top biopharmaceutical companies, Alloy fosters collaboration while also co-building new biotech ventures through its affiliated Venture Studio, 82VS.
|
iC³ Sponsor Spotlight: Munck Wilson Mandala
|
Munck Wilson Mandala is a technology-driven law firm with offices in Texas, California, and Florida, offering comprehensive legal services in intellectual property litigation, complex commercial disputes, corporate transactions, and employment law. The firm serves a diverse client base, from innovative startups to Fortune 50 corporations.
|
iC³ Sponsor Spotlight: RSM
|
RSM is the leading provider of professional services to the middle market, empowering businesses that drive global commerce and economic growth. Focused on developing top talent and services, RSM helps clients navigate the evolving business landscape with confidence. As the U.S. member of RSM International, a global network with 64,000 professionals across 120 countries, RSM offers expertise in assurance, tax, and consulting to help clients and their teams realize their full potential.
|
iC³ Sponsor Spotlight: Health Wildcatters
|
Since its inception in 2013, the Health Wildcatters portfolio has grown to 109 startups who have raised over $250 million. Health Wildcatters provides a seed investment, in-kind perks and a vast network of mentors comprised of well over 200 individuals spanning the healthcare industry, professional services and many other verticals.
|
iC³ Sponsor Spotlight: BHIANT
|
The Biotechnology and Healthcare Industry Alliance of North Texas (BHIANT) is committed to driving innovation in biotechnology and healthcare across the North Texas region. Through strategic partnerships, resource support, and industry advocacy, BHIANT plays a vital role in building a strong ecosystem and developing a skilled workforce to support the region's growth in these sectors.
|
iC³ Sponsor Spotlight: JacobsWyper Architects
|
JacobsWyper Architects, a renowned firm based in Philadelphia, excels in creating award-winning facilities for global pharmaceutical and biotech companies. Their expertise also spans a variety of environments, including research labs, academic and performing arts, student residences, museums, and modern workplaces.
|
Thank You 2024 iC³ Sponsors!
|
|
